Gdansk, Poland

Joanna Boros-Majewska

This inventor holds 2 USPTO granted patents. Top assignee: Blirt S.a.. Active years: 2016-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joanna Boros-Majewska. Retrieved from https://idiyas.com/inventor/joanna-boros-majewska

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 8.9

ph-index = 1


Company Filing History:


Years Active: 2016-2017

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Joanna Boros-Majewska: Innovator in Antifungal Antibiotics

Introduction

Joanna Boros-Majewska is a prominent inventor based in Gdansk, Poland. She has made significant contributions to the field of antifungal antibiotics, holding 2 patents that showcase her innovative approach to pharmaceutical development.

Latest Patents

Her latest patents include semisynthetic N-substituted second generation derivatives of the antifungal antibiotic amphotericin B. This invention provides water-soluble salts and complexes, pharmaceutical compositions, and plant and building treatment products that utilize these derivatives as antifungal antibiotics. Another notable patent involves semisynthetic derivatives of Nystatin A, which also includes water-soluble salts and complexes, along with their applications in pharmaceutical compositions and plant protection products.

Career Highlights

Joanna works at Blirt S.A., where she continues to advance her research and development in the field of antifungal treatments. Her work is characterized by a commitment to improving the efficacy and safety of antifungal medications.

Collaborations

She collaborates with notable colleagues, including Edward Borowski and Natalia Salewska, who contribute to her research endeavors and help drive innovation within her projects.

Conclusion

Joanna Boros-Majewska's contributions to antifungal antibiotics reflect her dedication to advancing medical science. Her innovative patents and collaborative efforts position her as a key figure in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…